亚太药业：连续两日股价涨幅偏离值累计超20%，提示风险

Core Viewpoint - The stock of Asia Pacific Pharmaceutical experienced an abnormal price fluctuation, with a cumulative increase of over 20% in closing prices over two consecutive trading days on October 31 and November 3, 2025 [1] Group 1: Stock Performance - The company's stock price showed a significant deviation, with a cumulative increase exceeding 20% over two trading days [1] - The company confirmed that there were no major changes in recent operations or the business environment [1] Group 2: Share Transfer - On October 13, 2025, the controlling shareholder, Fubon Group, and its concerted parties plan to transfer 14.61% of shares, totaling 108,945,566 shares, for a total price of 900 million [1] - Following the share transfer, the actual controller will change to Qiu Zhongxun [1] Group 3: Capital Increase - The company plans to conduct a private placement to Xinghao Holdings, which constitutes a related party transaction [1] - Both the share transfer and the private placement involve uncertainties, prompting the company to remind investors to pay attention to risks [1]